Appeal No. 1997-2744 Application No. 08/243,520 THE REJECTION UNDER 35 U.S.C. § 103: Initially, we note the examiner’s statement of the rejection (Answer, ¶ 11) “[c]laims 15-23 are rejected under 35 USC 103. This rejection is set forth in the prior Office action of September 20, 1994 paper number 18.” This statement appears to be in error. Paper number 18 refers to a rejection of claims 1-12, not claims 15-23. In fact this record never contained 23 claims. Furthermore, while both the examiner’s Answer (¶ 13) and appellants’ Brief refer to the combination of Isgaard and Mueller, Paper No. 18 sets forth a single rejection under 35 U.S.C. § 103 over Isgaard. Therefore, since the most recent Final Rejection5 of the claims is more consistent with the arguments of the examiner and appellants we believe the examiner intended to refer to this paper for the basis of the rejection. With this clarification, we proceed to address the merits of the examiner’s rejection. The initial burden of presenting a prima facie case of obviousness rests on the examiner. In re Oetiker, 977 F.2d 1443, 1445, 24 USPQ2d 1443, 1444 (Fed. Cir. 1992). In satisfying this initial burden, “[i]t is impermissible within the framework of section 103 to pick and choose from any one reference only so much of it as will support a given position to the exclusion of other parts necessary to the full appreciation of what such reference fairly suggests to one of ordinary skill in the art.” In re Wesslau, 353 F.2d 238, 241, 147 USPQ 391, 393 (CCPA 1965); see also In re Mercier, 515 F.2d 1161, 1165-66, 185 USPQ 774, 778 (CCPA 1975). The examiner finds (Answer, bridging paragraph, pages 3-4) that “Mueller teaches that appellants’ active [sic] used to treat experimental rats [sic] used to 3Page: Previous 1 2 3 4 5 6 7 NextLast modified: November 3, 2007